On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration took actions to help provide safe, effective, and more affordable drugs to American patients as part of the Safe Importation Action Plan.

The final rule implemented a provision of federal law that allows FDA-authorized programs to import certain prescription drugs from Canada under specific conditions that ensure the importation poses no additional risk to the publicﾒs health and safety while achieving a reduction in the cost of covered products to the American consumer.